prednisone has been researched along with Mast-Cell Sarcoma in 5 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Mast-Cell Sarcoma: A unifocal malignant tumor that consists of atypical pathological MAST CELLS without systemic involvement. It causes local destructive growth in organs other than in skin or bone marrow.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Systemic mastocytosis is a rare and occasionally aggressive condition that raises major diagnostic challenges." | 1.32 | Aggressive systemic mastocytosis. ( Bertin, P; Inaoui, R; Jaccard, A; Petit, B; Trèves, R, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lejeune, A | 1 |
| Skorupski, K | 1 |
| Frazier, S | 1 |
| Vanhaezebrouck, I | 1 |
| Rebhun, RB | 1 |
| Reilly, CM | 1 |
| Rodriguez, CO | 1 |
| Inaoui, R | 1 |
| Petit, B | 1 |
| Jaccard, A | 1 |
| Bertin, P | 1 |
| Trèves, R | 1 |
| Thamm, DH | 1 |
| Turek, MM | 1 |
| Vail, DM | 1 |
| Stanclift, RM | 1 |
| Gilson, SD | 1 |
| Rosenthal, RC | 1 |
1 review available for prednisone and Mast-Cell Sarcoma
| Article | Year |
|---|---|
Hormones in cancer therapy.
Topics: Adrenal Cortex Hormones; Animals; Cats; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Gonad | 1982 |
4 other studies available for prednisone and Mast-Cell Sarcoma
| Article | Year |
|---|---|
Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012).
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, | 2015 |
Aggressive systemic mastocytosis.
Topics: Aged; Alendronate; Bone Marrow Cells; Fatal Outcome; Female; Humans; Interferon-alpha; Leukemia, Mye | 2003 |
Outcome and prognostic factors following adjuvant prednisone/vinblastine chemotherapy for high-risk canine mast cell tumour: 61 cases.
Topics: Animals; Antineoplastic Agents; Chemotherapy, Adjuvant; Cohort Studies; Dog Diseases; Dogs; Female; | 2006 |
Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs.
Topics: Animals; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Disease-Free Survival; Dog Dise | 2008 |